NO792792L - Immunomodulatorer og antivirale midler - Google Patents

Immunomodulatorer og antivirale midler

Info

Publication number
NO792792L
NO792792L NO792792A NO792792A NO792792L NO 792792 L NO792792 L NO 792792L NO 792792 A NO792792 A NO 792792A NO 792792 A NO792792 A NO 792792A NO 792792 L NO792792 L NO 792792L
Authority
NO
Norway
Prior art keywords
activity
immunomodulators
carbon atoms
antiviral agents
alkyl
Prior art date
Application number
NO792792A
Other languages
English (en)
Other versions
NO152445B (no
NO152445C (no
Inventor
Lionel Norton Simon
John Winthrop Hadden
Original Assignee
Newport Pharmaceuticals
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newport Pharmaceuticals, Sloan Kettering Inst Cancer filed Critical Newport Pharmaceuticals
Publication of NO792792L publication Critical patent/NO792792L/no
Publication of NO152445B publication Critical patent/NO152445B/no
Publication of NO152445C publication Critical patent/NO152445C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/36—Sulfur atom
    • C07D473/38—Sulfur atom attached in position 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO792792A 1978-09-15 1979-08-28 Analogifremgangsmaate til fremstilling av terapeutisk aktive 9-(hydroksylalkyl)puriner NO152445C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/942,802 US4221909A (en) 1978-09-15 1978-09-15 P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines

Publications (3)

Publication Number Publication Date
NO792792L true NO792792L (no) 1980-03-18
NO152445B NO152445B (no) 1985-06-24
NO152445C NO152445C (no) 1985-10-02

Family

ID=25478620

Family Applications (1)

Application Number Title Priority Date Filing Date
NO792792A NO152445C (no) 1978-09-15 1979-08-28 Analogifremgangsmaate til fremstilling av terapeutisk aktive 9-(hydroksylalkyl)puriner

Country Status (27)

Country Link
US (1) US4221909A (no)
EP (1) EP0009154B1 (no)
JP (1) JPS5547683A (no)
KR (1) KR840000552A (no)
AT (1) ATE1949T1 (no)
AU (1) AU527851B2 (no)
CA (1) CA1122217A (no)
CS (1) CS251060B2 (no)
DD (1) DD146049A5 (no)
DE (1) DE2964211D1 (no)
DK (1) DK149857C (no)
ES (1) ES484167A1 (no)
FI (1) FI68234C (no)
GR (1) GR74076B (no)
HU (1) HU182544B (no)
IE (1) IE48827B1 (no)
IL (1) IL58087A (no)
IN (1) IN153099B (no)
MX (1) MX6521E (no)
NO (1) NO152445C (no)
NZ (1) NZ191483A (no)
PH (1) PH16315A (no)
PL (2) PL124515B1 (no)
PT (1) PT70180A (no)
RO (1) RO77565A (no)
YU (1) YU41884B (no)
ZA (1) ZA793973B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340726A (en) * 1980-03-14 1982-07-20 Newport Pharmaceuticals International, Inc. Esters
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
US4849411A (en) * 1982-11-09 1989-07-18 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US5147636A (en) * 1982-11-09 1992-09-15 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives and interferons
HUT36464A (en) * 1983-05-24 1985-09-30 Newport Pharmaceuticals Process for producing erythro-4-amino-3-/2-hydroxy-3-alkyl/-imidazol-5-carboxamide
IT1215339B (it) * 1987-01-14 1990-02-08 Co Pharma Corp Srl Procedimento per la preparazione di 9-(idrossialchil)-ipoxantine
US5091432A (en) * 1990-03-28 1992-02-25 Glasky Alvin J 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use
US5614504A (en) * 1990-08-01 1997-03-25 The University Of South Florida Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
PL318293A1 (en) 1994-07-25 1997-06-09 Alvin J Glasky Carbon monoxide dependent guanilyl cyclase modifiers
CA2199615A1 (en) * 1996-02-12 1997-08-14 Elie Abushanab Erythro-hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemia traits
AU3786299A (en) 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6297226B1 (en) 1999-10-15 2001-10-02 Neotherapeutics, Inc. Synthesis and methods of use of 9-substituted guanine derivatives
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
ATE499103T1 (de) 2000-07-07 2011-03-15 Spectrum Pharmaceuticals Inc Verfahren zur behandlung von arzneimittelinduzierter peripherer neuropathie und verwandten krankheitsformen
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CA2540598C (en) * 2003-10-03 2013-09-24 3M Innovative Properties Company Pyrazolopyridines and analogs thereof
WO2005074946A1 (en) * 2004-02-10 2005-08-18 Adenobio N.V. Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3215696A (en) * 1965-11-02 Substituted adenines -and preparation thereof
US3728450A (en) * 1969-08-28 1973-04-17 Newport Pharmaceuticals Inosine derivatives
BE755361A (fr) * 1969-08-28 1971-03-01 Newport Pharmaceuticals Derives de l'inosine
US3857940A (en) * 1971-05-21 1974-12-31 Newport Pharmaceuticals Inosine derivatives
US3836656A (en) * 1972-02-07 1974-09-17 Sandoz Ag Substituted purines as hypolipidemics
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
YU96177A (en) * 1976-04-24 1982-08-31 Wuelfing Johann A Process for obtaining adenine derivatives

Also Published As

Publication number Publication date
IE791753L (en) 1980-03-15
PL119685B1 (en) 1982-01-30
AU527851B2 (en) 1983-03-24
AU5055779A (en) 1980-03-20
IE48827B1 (en) 1985-05-29
CA1122217A (en) 1982-04-20
ES484167A1 (es) 1980-09-01
YU41884B (en) 1988-02-29
PT70180A (en) 1979-10-01
ATE1949T1 (de) 1982-12-15
PL124515B1 (en) 1983-01-31
NZ191483A (en) 1983-06-14
EP0009154B1 (en) 1982-12-08
YU224579A (en) 1983-12-31
RO77565A (ro) 1981-11-04
NO152445B (no) 1985-06-24
US4221909A (en) 1980-09-09
CS251060B2 (en) 1987-06-11
FI792849A (fi) 1980-03-16
IL58087A (en) 1983-03-31
KR840000552A (ko) 1984-02-25
EP0009154A1 (en) 1980-04-02
DK149857B (da) 1986-10-13
DD146049A5 (de) 1981-01-21
GR74076B (no) 1984-06-06
PH16315A (en) 1983-09-05
ZA793973B (en) 1980-09-24
JPH031309B2 (no) 1991-01-10
DK149857C (da) 1987-03-02
FI68234C (fi) 1985-08-12
FI68234B (fi) 1985-04-30
DK385679A (da) 1980-03-16
NO152445C (no) 1985-10-02
HU182544B (en) 1984-02-28
DE2964211D1 (en) 1983-01-13
IN153099B (no) 1984-06-02
JPS5547683A (en) 1980-04-04
MX6521E (es) 1985-06-27
PL218317A1 (no) 1980-06-16

Similar Documents

Publication Publication Date Title
NO792792L (no) Immunomodulatorer og antivirale midler
IL69292A (en) Muramyl peptides substituted by 1,2-diacylated-sn-glycero-3-hydroxyphosphoryl,their manufacture and pharmaceutical compositions containing them
ES8204416A1 (es) Un procedimiento para la produccion de un derivado de benza-mida
ZA848092B (en) Use of quinoline derivatives for the protection of cultivated plants
DK440987A (da) Thyroninderivater, deres fremstilling og anvendelse
GB2019843A (en) N-Alkenylmoranoline derivatives
GB8613913D0 (en) Microbicidal agrochemical compositions
ES8106147A1 (es) Procedimiento para preparar un 1,2,4-triazol-3-tiol
SE8801264D0 (sv) Organiska foreningar
KR840001150A (ko) 치환페닐(티오노)카바메이트의 제조방법
GB1548278A (en) Preparation of pyrryl-acetonitriles
ES8107202A1 (es) Procedimiento para preparar nuevos derivados de oxadiazolin-1,3,4-ona-5.
GB2011399A (en) Bactericidal compositions
SE8302972L (sv) Nya karbamidkompositioner
GB2005250A (en) (1-Alkylpyrrolyl-2)thio- acetamides
GB2022075A (en) Lactam-N-acetic acids and the preparation thereof
ES472090A2 (es) Mejoras introducidas en el objeto de la patente principal n.451407 por:procedimiento para preparar derivados de amidoxi-ma
ES8302712A1 (es) Un nuevo procedimiento de preparacion de imidazobenzodiazepinas.